Improving sun protection for melanoma survivors using mobile health tools
SESAME: Sun Exposure and Activities after Skin CAncer: Optimization of Mhealth IntErventions
This study is testing a helpful mobile app for melanoma survivors that gives real-time tips on staying safe in the sun while also encouraging them to stay active, making it easier for them to protect their skin and maintain a healthy lifestyle.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10872417 on NIH RePORTER |
What this research studies
This research focuses on developing mobile health (mHealth) interventions to help melanoma survivors better protect themselves from harmful sun exposure. It aims to provide real-time information and feedback on sun protection while encouraging physical activity, which often declines after a melanoma diagnosis. By utilizing a framework called the Multiphase Optimization Strategy (MOST), the study seeks to refine existing intervention tools to maximize their effectiveness. The goal is to create a comprehensive approach that addresses both sun safety and the maintenance of an active lifestyle.
Who could benefit from this research
Good fit: Ideal candidates for this research are melanoma survivors who are 21 years or older and are looking for effective ways to manage their sun exposure.
Not a fit: Patients who are not melanoma survivors or those who do not engage in outdoor activities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the risk of new melanoma cases among survivors by improving their sun protection behaviors.
How similar studies have performed: Previous research has shown promise in using mobile health interventions for health behavior changes, indicating potential success for this approach.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Alshurafa, Nabil — Northwestern University at Chicago
- Study coordinator: Alshurafa, Nabil
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.